Vanguard Global Advisers’s Opus Genetics IRD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRD
Vanguard Global Advisers's IRD Position: Q3 2026 in Review
Vanguard Global Advisers increased its Opus Genetics (IRD) stake by 348% in Q3 2026, buying an estimated $207K and bringing the position to 64,274 shares worth $311K. The position accounts for ﹤0.01% of the portfolio, ranked #2306.
Vanguard Global Advisers first reported a position in IRD in Q1 2026 and has held it in 3 quarters since. 114 funds tracked by Wall St. Rank hold IRD as of Q3 2026.
- Vanguard Global Advisers held 64,274 shares of Opus Genetics worth $311K as of Q3 2026.
- Vanguard Global Advisers bought 49,932 Opus Genetics shares in Q3 2026, an estimated $207K.
- Opus Genetics made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2306 holding.
- Vanguard Global Advisers first reported a position in Opus Genetics in Q1 2026 and has held it in 3 quarters since.
- 114 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.